File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis

TitleMitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis
Authors
KeywordsBRCA1
Cisplatin sensitivity
MFF
MiR-593-5p
Mitochondrial fission
Issue Date2015
PublisherImpact Journals LLC. The Journal's web site is located at http://www.impactjournals.com/oncotarget/index.html
Citation
Oncotarget, 2015, v. 6 n. 17, p. 14885-14904 How to Cite?
AbstractCisplatin has been widely employed as a cornerstone chemotherapy treatment for a wide spectrum of solid neoplasms; increasing tumor responsiveness to cisplatin has been a topic of interest for the past 30 years. Strong evidence has indicated that mitochondrial fission participates in the regulation of apoptosis in many diseases; however, whether mitochondrial fission regulates cisplatin sensitivity remains poorly understood. Here, we show that MFF mediated mitochondrial fission and apoptosis in tongue squamous cell carcinoma (TSCC) cells after cisplatin treatment and that miR-593-5p was downregulated in this process. miR-593-5p attenuated mitochondrial fission and cisplatin sensitivity by targeting the 3’ untranslated region sequence of MFF and inhibiting its translation. In exploring the underlying mechanism of miR-593-5p downregulation, we observed that BRCA1 transactivated miR-593-5p expression and attenuated cisplatin sensitivity in vitro. The BRCA1-miR-593-5p-MFF axis also affected cisplatin sensitivity in vivo. Importantly, in a retrospective analysis of multiple centers, we further found that the BRCA1-miR-593-5p-MFF axis was significantly associated with cisplatin sensitivity and the survival of patients with TSCC. Together, our data reveal a model for mitochondrial fission regulation at the transcriptional and post-transcriptional levels; we also reveal a new pathway for BRCA1 in determining cisplatin sensitivity through the mitochondrial fission program.
Persistent Identifierhttp://hdl.handle.net/10722/211689
ISSN
2016 Impact Factor: 5.168
2023 SCImago Journal Rankings: 0.789
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorFan, S-
dc.contributor.authorLiu, B-
dc.contributor.authorSun, L-
dc.contributor.authorLv, XB-
dc.contributor.authorLin, Z-
dc.contributor.authorChen, W-
dc.contributor.authorTang, Q-
dc.contributor.authorWang, Y-
dc.contributor.authorSu, Y-
dc.contributor.authorJin, S-
dc.contributor.authorZhang, D-
dc.contributor.authorZhong, J-
dc.contributor.authorLi, Y-
dc.contributor.authorWen, B-
dc.contributor.authorZhang, Z-
dc.contributor.authorYang, P-
dc.contributor.authorZhou, B-
dc.contributor.authorLiang, Q-
dc.contributor.authorYu, X-
dc.contributor.authorZhu, Y-
dc.contributor.authorHu, P-
dc.contributor.authorChu, J-
dc.contributor.authorHuang, W-
dc.contributor.authorFeng, Y-
dc.contributor.authorPeng, H-
dc.contributor.authorHuang, Q-
dc.contributor.authorSong, E-
dc.contributor.authorLi, J-
dc.date.accessioned2015-07-21T02:07:59Z-
dc.date.available2015-07-21T02:07:59Z-
dc.date.issued2015-
dc.identifier.citationOncotarget, 2015, v. 6 n. 17, p. 14885-14904-
dc.identifier.issn1949-2553-
dc.identifier.urihttp://hdl.handle.net/10722/211689-
dc.description.abstractCisplatin has been widely employed as a cornerstone chemotherapy treatment for a wide spectrum of solid neoplasms; increasing tumor responsiveness to cisplatin has been a topic of interest for the past 30 years. Strong evidence has indicated that mitochondrial fission participates in the regulation of apoptosis in many diseases; however, whether mitochondrial fission regulates cisplatin sensitivity remains poorly understood. Here, we show that MFF mediated mitochondrial fission and apoptosis in tongue squamous cell carcinoma (TSCC) cells after cisplatin treatment and that miR-593-5p was downregulated in this process. miR-593-5p attenuated mitochondrial fission and cisplatin sensitivity by targeting the 3’ untranslated region sequence of MFF and inhibiting its translation. In exploring the underlying mechanism of miR-593-5p downregulation, we observed that BRCA1 transactivated miR-593-5p expression and attenuated cisplatin sensitivity in vitro. The BRCA1-miR-593-5p-MFF axis also affected cisplatin sensitivity in vivo. Importantly, in a retrospective analysis of multiple centers, we further found that the BRCA1-miR-593-5p-MFF axis was significantly associated with cisplatin sensitivity and the survival of patients with TSCC. Together, our data reveal a model for mitochondrial fission regulation at the transcriptional and post-transcriptional levels; we also reveal a new pathway for BRCA1 in determining cisplatin sensitivity through the mitochondrial fission program.-
dc.languageeng-
dc.publisherImpact Journals LLC. The Journal's web site is located at http://www.impactjournals.com/oncotarget/index.html-
dc.relation.ispartofOncotarget-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectBRCA1-
dc.subjectCisplatin sensitivity-
dc.subjectMFF-
dc.subjectMiR-593-5p-
dc.subjectMitochondrial fission-
dc.titleMitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis-
dc.typeArticle-
dc.identifier.emailSu, Y: richsu@hku.hk-
dc.identifier.authoritySu, Y=rp01916-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.18632/oncotarget.3659-
dc.identifier.pmid25912308-
dc.identifier.scopuseid_2-s2.0-84934324649-
dc.identifier.hkuros245348-
dc.identifier.volume6-
dc.identifier.issue17-
dc.identifier.spage14885-
dc.identifier.epage14904-
dc.identifier.isiWOS:000359010700020-
dc.publisher.placeUnited States-
dc.identifier.issnl1949-2553-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats